Peripheral Arterial Diseases
17
3
3
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
41%
7 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (17)
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone
Transcutaneous Oxygen Pressure (TcPO2) Determination.
Lower Extremity Peripheral Arterial Disease and Exercise Ischemia
Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB
EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery
Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.
Effects of Remote Ischemic Preconditioning on Moderate PVD Patients A Pilot Randomized Control Trial
Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes
The Jetstream (JET) Post-market Registry
PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses
Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)
Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent
Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography
Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease